OUR MISSION
Our mission is simple, and it is not for everyone. We exist to make the impossible connections possible — to accelerate innovation and to ensure that the most important innovations in neuroscience find the people, capital, and partners they need to reach patients.
WHY NEUROSCIENCE
We chose neuroscience because it is the most complex, most important, and most underserved frontier in medicine. The brain is the final territory of discovery. Its diseases — Alzheimer's, Parkinson's, ALS, rare neurological conditions, treatment-resistant psychiatric disorders — represent some of the heaviest burdens of human suffering. And the moment for breakthroughs has arrived.
New science, new tools, new biology, and a new generation of founders and investors are converging. But convergence does not happen on its own. It requires infrastructure — and that infrastructure is built on relationships.
OUR NETWORK IS OUR WORK
Over more than two decades, we have built — one conversation, one introduction, one meeting, one event at a time — a network that connects the leadership of the global neuroscience sector. The CEOs and C-suite of the most consequential private biotech companies. The heads of therapeutic areas, business development, scouting and licensing at the world's leading pharma. The managing partners of the most active neuroscience investment funds. The scientists and clinicians whose ideas become the therapies of tomorrow.
This network is not best described.
It must be experienced in person.
HOW WE WORK
We are highly selective in the work we take on. We work with a small number of partners at any time — biotech companies navigating a critical strategic inflection, investors seeking prioritized access and sector intelligence, pharma leaders looking to engage the innovation ecosystem before it becomes obvious.
​
What we offer is not a menu. It emerges from a deep understanding of where you are, where you need to go, and who you need to be in the room with to get there.